Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{$index + 1}}. {{ watchedTerm.term }} ({{watchedTerm.accId}})
{{gene.symbol}}: {{ gene.description }}
You must be logged in to use this feature
{{ loginError }}
Select categories you would like to watch. Updates to this gene will be sent to {{ username }}
x
Send Message
Gene: Clcnka (chloride voltage-gated channel Ka) Rattus norvegicus
Analyze
Symbol:
Clcnka
Name:
chloride voltage-gated channel Ka
RGD ID:
68435
Description:
Enables chloride channel activity and voltage-gated monoatomic ion channel activity. Involved in several processes, including body fluid secretion; response to calcium ion; and response to pH. Located in apical plasma membrane and basolateral plasma membrane. Human ortholog(s) of this gene implicated in Bartter disease type 4b and sensorineural hearing loss. Orthologous to human CLCNKA (chloride voltage-gated channel Ka); PARTICIPATES IN amiloride pharmacodynamics pathway; bendroflumethiazide pharmacodynamics pathway; bumetanide pharmacodynamics pathway; INTERACTS WITH (4-chloro-2-methylphenoxy)acetic acid; 4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid; 6-propyl-2-thiouracil.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
chloride channel K1; chloride channel Ka; chloride channel protein ClC-Ka; chloride channel, voltage-sensitive Ka; clC-K1; Clcnk1; MGC93313
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 5 158,974,190 - 158,989,275 (-) NCBI GRCr8 GRCr8 GRCr8 GRCr8 Ensembl 5 158,974,193 - 158,989,128 (-) Ensembl GRCr8 mRatBN7.2 5 153,691,208 - 153,706,295 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 5 153,691,209 - 153,706,148 (-) Ensembl mRatBN7.2 UTH_Rnor_SHR_Utx 5 156,378,149 - 156,393,093 (-) NCBI UTH_Rnor_SHR_Utx UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 5 158,151,434 - 158,166,379 (-) NCBI UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 5 158,140,613 - 158,155,555 (-) NCBI UTH_Rnor_WKY_Bbb_1.0 UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 5 159,931,497 - 159,946,483 (-) NCBI Rnor_6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 5 159,931,511 - 159,946,446 (-) Ensembl rn6 Rnor6.0 Rnor_5.0 5 163,651,964 - 163,667,008 (-) NCBI Rnor_5.0 Rnor_5.0 rn5 RGSC_v3.4 5 160,274,377 - 160,290,369 (-) NCBI RGSC_v3.4 RGSC_v3.4 rn4 Celera 5 152,055,371 - 152,067,986 (-) NCBI Celera RGSC_v3.1 5 160,284,564 - 160,300,557 (-) NCBI Cytogenetic Map 5 q36 NCBI
JBrowse:
Imported Disease Annotations - ClinVar
Imported Disease Annotations - CTD
Imported Disease Annotations - MGI
Imported Disease Annotations - OMIM
Only show annotations with direct experimental evidence (0 objects hidden)
Clcnka Rat (4-chloro-2-methylphenoxy)acetic acid decreases activity EXP 6480464 2-Methyl-4-chlorophenoxyacetic Acid analog results in decreased activity of CLCNKA protein CTD PMID:15167890 Clcnka Rat 1,1-dichloroethene decreases expression ISO Clcnka (Mus musculus) 6480464 vinylidene chloride results in decreased expression of CLCNKA mRNA CTD PMID:26682919 Clcnka Rat 17beta-estradiol multiple interactions ISO CLCNKA (Homo sapiens) 6480464 [Estradiol binds to ESR2 protein] which results in increased expression of CLCNKA mRNA CTD PMID:20404318 Clcnka Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Clcnka (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of CLCNKA mRNA CTD PMID:20702594 Clcnka Rat 3,3',4,4',5-pentachlorobiphenyl affects expression ISO Clcnka (Mus musculus) 6480464 3,4,5,3',4'-pentachlorobiphenyl affects the expression of CLCNKA mRNA CTD PMID:20702594 Clcnka Rat 4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid decreases activity EXP 6480464 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid analog results in decreased activity of CLCNKA protein CTD PMID:15167890 Clcnka Rat 4,4'-sulfonyldiphenol decreases methylation ISO Clcnka (Mus musculus) 6480464 bisphenol S results in decreased methylation of CLCNKA promoter CTD PMID:33297965 Clcnka Rat 5-aza-2'-deoxycytidine affects expression ISO CLCNKA (Homo sapiens) 6480464 Decitabine affects the expression of CLCNKA mRNA CTD PMID:23300844 Clcnka Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of CLCNKA mRNA CTD PMID:24780913 Clcnka Rat aflatoxin B1 increases methylation ISO CLCNKA (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of CLCNKA gene CTD PMID:27153756 Clcnka Rat all-trans-retinoic acid decreases expression ISO CLCNKA (Homo sapiens) 6480464 Tretinoin results in decreased expression of CLCNKA mRNA CTD PMID:15498508 Clcnka Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CLCNKA mRNA CTD PMID:16483693 Clcnka Rat benzo[a]pyrene increases expression ISO Clcnka (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of CLCNKA mRNA CTD PMID:27195522 Clcnka Rat benzo[a]pyrene affects methylation ISO CLCNKA (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of CLCNKA 5' UTR CTD PMID:27901495 Clcnka Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CLCNKA mRNA CTD PMID:25181051 Clcnka Rat bisphenol A decreases methylation ISO Clcnka (Mus musculus) 6480464 bisphenol A results in decreased methylation of CLCNKA promoter CTD PMID:27312807 Clcnka Rat Butylbenzyl phthalate decreases methylation ISO Clcnka (Mus musculus) 6480464 butylbenzyl phthalate results in decreased methylation of CLCNKA intron CTD PMID:28392331 Clcnka Rat cisplatin affects expression ISO CLCNKA (Homo sapiens) 6480464 Cisplatin affects the expression of CLCNKA mRNA CTD PMID:23300844 Clcnka Rat CPP decreases activity EXP 6480464 2-(4-chlorophenoxy)propionic acid analog results in decreased activity of CLCNKA protein CTD PMID:12130677|PMID:14694153 Clcnka Rat Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of CLCNKA mRNA CTD PMID:26577399 Clcnka Rat furosemide decreases expression EXP 6480464 Furosemide results in decreased expression of CLCNKA mRNA CTD PMID:12759757 Clcnka Rat O-methyleugenol decreases expression ISO CLCNKA (Homo sapiens) 6480464 methyleugenol results in decreased expression of CLCNKA mRNA CTD PMID:32234424 Clcnka Rat okadaic acid decreases expression ISO CLCNKA (Homo sapiens) 6480464 Okadaic Acid results in decreased expression of CLCNKA mRNA CTD PMID:38832940 Clcnka Rat pentachlorophenol increases expression ISO Clcnka (Mus musculus) 6480464 Pentachlorophenol results in increased expression of CLCNKA mRNA CTD PMID:23892564 Clcnka Rat sodium arsenite increases expression ISO Clcnka (Mus musculus) 6480464 sodium arsenite results in increased expression of CLCNKA mRNA CTD PMID:37682722 Clcnka Rat stilbenoid decreases activity EXP 6480464 Stilbenes analog results in decreased activity of CLCNKA protein CTD PMID:14694153 Clcnka Rat tamibarotene decreases expression ISO CLCNKA (Homo sapiens) 6480464 tamibarotene results in decreased expression of CLCNKA mRNA CTD PMID:15498508 Clcnka Rat valproic acid increases methylation ISO CLCNKA (Homo sapiens) 6480464 Valproic Acid results in increased methylation of CLCNKA gene CTD PMID:29154799 Clcnka Rat VX nerve agent increases expression ISO CLCNKA (Homo sapiens) 6480464 VX-agent results in increased expression of CLCNKA mRNA CTD PMID:38555327 Clcnka Rat zoledronic acid decreases expression ISO CLCNKA (Homo sapiens) 6480464 zoledronic acid results in decreased expression of CLCNKA mRNA CTD PMID:24714768
Imported Annotations - SMPDB
QTLs in Region (GRCr8)
10053720 Scort26 Serum corticosterone level QTL 26 2.06 0.0147 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 5 130249266 172190305 Rat 8552960 Pigfal15 Plasma insulin-like growth factor 1 level QTL 15 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 5 116702075 161702075 Rat 1354583 Despr3 Despair related QTL3 4.98 0.0002 locomotor behavior trait (VT:0001392) amount of time spent in voluntary immobility (CMO:0001043) 5 132930505 172190305 Rat 61444 Strs2 Sensitivity to stroke QTL 2 4.7 cerebrum integrity trait (VT:0010549) post-insult time to onset of cerebrovascular lesion (CMO:0002343) 5 141212838 172190305 Rat 1300119 Bp180 Blood pressure QTL 180 3.82 arterial blood pressure trait (VT:2000000) blood pressure time series experimental set point of the baroreceptor response (CMO:0002593) 5 149642129 171146538 Rat 61452 Ciaa5 CIA Autoantibody QTL 5 3.5 blood autoantibody amount (VT:0003725) calculated serum anti-rat type 2 collagen autoantibody titer (CMO:0001281) 5 99905133 172190305 Rat 8552908 Pigfal4 Plasma insulin-like growth factor 1 level QTL 4 6.6 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 5 133789363 172190305 Rat 1331803 Rf32 Renal function QTL 32 2.798 kidney blood vessel physiology trait (VT:0100012) absolute change in renal vascular resistance (CMO:0001900) 5 134369199 172190305 Rat 61393 Bp7 Blood pressure QTL 7 4.5 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 65089051 166764498 Rat 7794791 Mcs33 Mammary carcinoma susceptibility QTL 33 1.93 mammary gland integrity trait (VT:0010552) mammary tumor incidence/prevalence measurement (CMO:0000946) 5 136631198 172190305 Rat 1354631 Swd2 Spike wave discharge measurement QTL 2 3.64 0.0002 brain electrophysiology trait (VT:0010557) brain total spike-and-wave discharge duration (CMO:0001740) 5 156396728 172190305 Rat 1598861 Cm64 Cardiac mass QTL 64 2.9 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 5 133081618 172190305 Rat 1578766 Tcas11 Tongue tumor susceptibility QTL 11 4.12 tongue integrity trait (VT:0010553) number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) 5 51657967 166600247 Rat 631263 Cm24 Cardiac mass QTL 24 3.5 heart mass (VT:0007028) heart left ventricle weight to body weight ratio (CMO:0000530) 5 149805999 162987697 Rat 631505 Bp103 Blood pressure QTL 103 3.2 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 138002522 170842766 Rat 1581505 Rf54 Renal function QTL 54 kidney physiology trait (VT:0002136) kidney 20-HETE level (CMO:0001854) 5 133270647 172190305 Rat 2317753 Glom24 Glomerulus QTL 24 3.1 kidney glomerulus integrity trait (VT:0010546) kidney sclerotic glomeruli count to total glomeruli count ratio (CMO:0001269) 5 141764300 172190305 Rat 8694169 Bw148 Body weight QTL 148 5 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 5 133789363 172190305 Rat 1331721 Bp210 Blood pressure QTL 210 3.413 arterial blood pressure trait (VT:2000000) blood pressure time series experimental set point of the baroreceptor response (CMO:0002593) 5 148093485 172129029 Rat 1581510 Cm54 Cardiac mass QTL 54 3.4 0.05 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 5 125969677 172190305 Rat 1576312 Emca8 Estrogen-induced mammary cancer QTL 8 4.1 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 5 55124766 172190305 Rat 631272 Lanf1 Left ventricular atrial natriuretic factor QTL 1 12 heart left ventricle natriuretic peptide A amount (VT:0010596) heart left ventricle natriuretic peptide A level (CMO:0002165) 5 156396728 167181764 Rat 724525 Bp147 Blood pressure QTL 147 4.3 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 131708216 172190305 Rat 1598847 Cm62 Cardiac mass QTL 62 3.4 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 5 114131300 159131300 Rat 2313096 Bmd78 Bone mineral density QTL 78 3.1 0.0001 tibia mineral mass (VT:1000283) total volumetric bone mineral density (CMO:0001728) 5 149661912 166600247 Rat 8694441 Bw169 Body weight QTL 169 17.61 0.001 retroperitoneal fat pad mass (VT:0010430) retroperitoneal fat pad weight to body weight ratio (CMO:0000635) 5 116702075 161702075 Rat 8694389 Bw160 Body weight QTL 160 6.17 0.001 body lean mass (VT:0010483) lean tissue morphological measurement (CMO:0002184) 5 116702075 161702075 Rat 8694198 Abfw3 Abdominal fat weight QTL 3 16.13 0.001 visceral adipose mass (VT:0010063) abdominal fat pad weight to body weight ratio (CMO:0000095) 5 116702075 161702075 Rat 1298090 Bp155 Blood pressure QTL 155 3.8 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 5 156289283 171137955 Rat 1298089 Scl14 Serum cholesterol level QTL 14 5.8 0.0004 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 5 114131300 159131300 Rat 1598819 Bp292 Blood pressure QTL 292 4.3 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 133081618 172190305 Rat